요로감염 검사 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for urinary tract infection (UTI) testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• UTI Testing Market Size (2024E): USD 634.5 Mn
• Projected Market Value (2031F): USD 960.3 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 6.1%

UTI Testing Market - Report Scope:

Urinary tract infection testing encompasses a variety of diagnostic methods, including urinalysis, urine culture, polymerase chain reaction (PCR), and rapid dipstick tests, to detect the presence of pathogens causing UTIs. The market caters to hospitals, clinics, diagnostic laboratories, and homecare settings, offering a range of test types, including point-of-care testing kits and laboratory-based assays. Market growth is driven by the increasing prevalence of UTIs, rising awareness about early diagnosis, and advancements in diagnostic technologies, enhancing test accuracy and patient outcomes.

Market Growth Drivers:

The global UTI testing market is propelled by several key factors, including the growing incidence of urinary tract infections, particularly among women, the elderly, and individuals with chronic conditions. Rising awareness about the importance of early diagnosis and treatment of UTIs further drives market expansion. Technological advancements, such as the development of rapid and highly sensitive diagnostic tests, offer improved accuracy and quicker results, fostering market growth. Moreover, the increasing adoption of point-of-care testing and the expansion of home-based diagnostic services create new avenues for market players to reach a wider patient population.

Market Restraints:

Despite promising growth prospects, the UTI testing market faces challenges related to regulatory compliance, reimbursement policies, and the high cost of advanced diagnostic tests. Stringent regulations governing the manufacturing, marketing, and use of diagnostic devices impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for UTI diagnostic tests and the high cost of advanced testing equipment pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to promote access to affordable and reliable UTI testing solutions.

Market Opportunities:

The UTI testing market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient access to diagnostic services and improves treatment adherence and outcomes. Furthermore, the expanding application of molecular diagnostics and the development of multiplex assays for simultaneous detection of multiple pathogens broaden the market scope and stimulate innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective diagnostic solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic UTI testing landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the UTI testing market globally?
• Which test types and applications are driving UTI testing adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the UTI testing market?
• Who are the key players contributing to the UTI testing market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global UTI testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global UTI testing market, including Siemens Healthineers, Abbott Laboratories, and Becton, Dickinson and Company (BD), focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, including molecular tests and rapid testing kits, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving UTI testing landscape.

Key Companies Profiled:

• ACON Laboratories Inc.
• Cardinal Health Inc.
• Danaher Corporation
• SYSMEX CORPORATION
• Abbott Laboratories
• Bio-Rad Laboratories
• Roche AG
• LabCorp (Laboratory Corporation of America Holdings).
• Stryker Corporation
• Thermo Fisher Scientific, Inc.

Urinary Tract Infection Testing Market Research Segmentation

By Tests:

• Urinalysis
• Urine Cultures
• Susceptibility Testing

By Tests Kits:

• Home Test Kits
• Laboratory Test Kits

By Indication:

• Cystitis
• Urethritis
• Pyelonephritis

By End User:

• Hospitals
• Nephropathy Clinics
• Diagnostic Laboratories

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Urinary Tract Infection Testing Market Snapshot, 2024-2031
• 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Tests Lifecycle Analysis
• 2.4. Global Urinary Tract Infection Testing Market: Value Chain
  • 2.4.1. List of Tests Kits Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Tests Kits Landscape

3. Global Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Mn ) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2019-2023
  • 3.2.2. Current Market Size Forecast, 2024-2031
• 3.3. Global Urinary Tract Infection Testing Market Outlook: Tests
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Tests, 2019-2023
  • 3.3.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 3.3.3.1. Urinalysis
    • 3.3.3.2. Urine Cultures
    • 3.3.3.3. Susceptibility Testing
• 3.4. Market Attractiveness Analysis: Tests
• 3.5. Global Urinary Tract Infection Testing Market Outlook: Tests Kits
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Tests Kits, 2019-2023
  • 3.5.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 3.5.3.1. Home Test Kits
    • 3.5.3.2. Laboratory Test Kits
• 3.6. Market Attractiveness Analysis: Tests Kits
• 3.7. Global Urinary Tract Infection Testing Market Outlook: Indication
  • 3.7.1. Introduction / Key Findings
  • 3.7.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Indication, 2019-2023
  • 3.7.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 3.7.3.1. Cystitis
    • 3.7.3.2. Urethritis
    • 3.7.3.3. Pyelonephritis
• 3.8. Market Attractiveness Analysis: Indication
• 3.9. Global Urinary Tract Infection Testing Market Outlook: End Use
  • 3.9.1. Introduction / Key Findings
  • 3.9.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By End Use, 2019-2023
  • 3.9.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 3.9.3.1. Hospitals
    • 3.9.3.2. Nephropathy Clinics
    • 3.9.3.3. Diagnostic Laboratories
    • 3.9.3.4. others
• 3.10. Market Attractiveness Analysis: End Use

4. Global Urinary Tract Infection Testing Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Region, 2019-2023
• 4.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Region, 2024-2031
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia and Oceania
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
  • 5.3.1. By Country
  • 5.3.2. By Tests
  • 5.3.3. By Tests Kits
  • 5.3.4. By Indication
  • 5.3.5. By End Use
• 5.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
  • 5.5.1. Urinalysis
  • 5.5.2. Urine Cultures
  • 5.5.3. Susceptibility Testing
• 5.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
  • 5.6.1. Home Test Kits
  • 5.6.2. Laboratory Test Kits
• 5.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
  • 5.7.1. Cystitis
  • 5.7.2. Urethritis
  • 5.7.3. Pyelonephritis
• 5.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
  • 5.8.1. Hospitals
  • 5.8.2. Nephropathy Clinics
  • 5.8.3. Diagnostic Laboratories
  • 5.8.4. others
• 5.9. Market Attractiveness Analysis

6. Europe Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
  • 6.3.1. By Country
  • 6.3.2. By Tests
  • 6.3.3. By Tests Kits
  • 6.3.4. By Indication
  • 6.3.5. By End Use
• 6.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkey
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
  • 6.5.1. Urinalysis
  • 6.5.2. Urine Cultures
  • 6.5.3. Susceptibility Testing
• 6.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
  • 6.6.1. Home Test Kits
  • 6.6.2. Laboratory Test Kits
• 6.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
  • 6.7.1. Cystitis
  • 6.7.2. Urethritis
  • 6.7.3. Pyelonephritis
• 6.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
  • 6.8.1. Hospitals
  • 6.8.2. Nephropathy Clinics
  • 6.8.3. Diagnostic Laboratories
  • 6.8.4. others
• 6.9. Market Attractiveness Analysis

7. East Asia Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
  • 7.3.1. By Country
  • 7.3.2. By Tests
  • 7.3.3. By Tests Kits
  • 7.3.4. By Indication
  • 7.3.5. By End Use
• 7.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
  • 7.5.1. Urinalysis
  • 7.5.2. Urine Cultures
  • 7.5.3. Susceptibility Testing
• 7.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
  • 7.6.1. Home Test Kits
  • 7.6.2. Laboratory Test Kits
• 7.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
  • 7.7.1. Cystitis
  • 7.7.2. Urethritis
  • 7.7.3. Pyelonephritis
• 7.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
  • 7.8.1. Hospitals
  • 7.8.2. Nephropathy Clinics
  • 7.8.3. Diagnostic Laboratories
  • 7.8.4. others
• 7.9. Market Attractiveness Analysis

8. South Asia & Oceania Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
  • 8.3.1. By Country
  • 8.3.2. By Tests
  • 8.3.3. By Tests Kits
  • 8.3.4. By Indication
  • 8.3.5. By End Use
• 8.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
  • 8.5.1. Urinalysis
  • 8.5.2. Urine Cultures
  • 8.5.3. Susceptibility Testing
• 8.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
  • 8.6.1. Home Test Kits
  • 8.6.2. Laboratory Test Kits
• 8.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
  • 8.7.1. Cystitis
  • 8.7.2. Urethritis
  • 8.7.3. Pyelonephritis
• 8.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
  • 8.8.1. Hospitals
  • 8.8.2. Nephropathy Clinics
  • 8.8.3. Diagnostic Laboratories
  • 8.8.4. others
• 8.9. Market Attractiveness Analysis

9. Latin America Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
  • 9.3.1. By Country
  • 9.3.2. By Tests
  • 9.3.3. By Tests Kits
  • 9.3.4. By Indication
  • 9.3.5. By End Use
• 9.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
  • 9.5.1. Urinalysis
  • 9.5.2. Urine Cultures
  • 9.5.3. Susceptibility Testing
• 9.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
  • 9.6.1. Home Test Kits
  • 9.6.2. Laboratory Test Kits
• 9.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
  • 9.7.1. Cystitis
  • 9.7.2. Urethritis
  • 9.7.3. Pyelonephritis
• 9.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
  • 9.8.1. Hospitals
  • 9.8.2. Nephropathy Clinics
  • 9.8.3. Diagnostic Laboratories
  • 9.8.4. others
• 9.9. Market Attractiveness Analysis

10. Middle East & Africa Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
  • 10.3.1. By Country
  • 10.3.2. By Tests
  • 10.3.3. By Tests Kits
  • 10.3.4. By Indication
  • 10.3.5. By End Use
• 10.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
  • 10.5.1. Urinalysis
  • 10.5.2. Urine Cultures
  • 10.5.3. Susceptibility Testing
• 10.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
  • 10.6.1. Home Test Kits
  • 10.6.2. Laboratory Test Kits
• 10.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
  • 10.7.1. Cystitis
  • 10.7.2. Urethritis
  • 10.7.3. Pyelonephritis
• 10.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
  • 10.8.1. Hospitals
  • 10.8.2. Nephropathy Clinics
  • 10.8.3. Diagnostic Laboratories
  • 10.8.4. others
• 10.9. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2024
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Dashboard
  • 11.2.3. Apparent Tests Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. ACON Laboratories Inc.
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Tests
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. Cardinal Health Inc.
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Tests
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Danaher Corporation
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Tests
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. SYSMEX CORPORATION
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Tests
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. Abbott Laboratories
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Tests
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy
  • 11.3.6. Bio-Rad Laboratories
    • 11.3.6.1. Overview
    • 11.3.6.2. Segments and Tests
    • 11.3.6.3. Key Financials
    • 11.3.6.4. Market Developments
    • 11.3.6.5. Market Strategy
  • 11.3.7. Roche AG
    • 11.3.7.1. Overview
    • 11.3.7.2. Segments and Tests
    • 11.3.7.3. Key Financials
    • 11.3.7.4. Market Developments
    • 11.3.7.5. Market Strategy
  • 11.3.8. LabCorp (Laboratory Corporation of America Holdings).
    • 11.3.8.1. Overview
    • 11.3.8.2. Segments and Tests
    • 11.3.8.3. Key Financials
    • 11.3.8.4. Market Developments
    • 11.3.8.5. Market Strategy
  • 11.3.9. Stryker Corporation
    • 11.3.9.1. Overview
    • 11.3.9.2. Segments and Tests
    • 11.3.9.3. Key Financials
    • 11.3.9.4. Market Developments
    • 11.3.9.5. Market Strategy
  • 11.3.10. Thermo Fisher Scientific, Inc.
    • 11.3.10.1. Overview
    • 11.3.10.2. Segments and Tests
    • 11.3.10.3. Key Financials
    • 11.3.10.4. Market Developments
    • 11.3.10.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations